3 November 2026
Latham & Watkins Advises Pelthos Therapeutics in Combination With Castle Creek Biosciences
Advising firms
Deal team
21 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Leah Sauter Lead | Latham & Watkins LLP | Partner | corporate | New York |
| Kyle Adams | Latham & Watkins LLP | Associate | corporate | Not stated |
| Christopher Lim | Latham & Watkins LLP | Associate | corporate | Not stated |
| Joey Yu | Latham & Watkins LLP | Associate | corporate | Not stated |
| Léa Nicolas | Latham & Watkins LLP | Not stated | corporate | Not stated |
| Elisabeth Martin | Latham & Watkins LLP | Partner | capital markets | Boston |
| Wesley Holmes | Latham & Watkins LLP | Partner | capital markets | Boston |
| Peter Handrinos | Latham & Watkins LLP | Partner | capital markets | Boston |
| Andrew Rutsky | Latham & Watkins LLP | Associate | capital markets | Not stated |
| Rich Reynolds | Latham & Watkins LLP | Associate | capital markets | Not stated |
| James Macdonald | Latham & Watkins LLP | Not stated | capital markets | Not stated |
| Michael Zucker | Latham & Watkins LLP | Partner | tax | Chicago |
| Jay Khurana | Latham & Watkins LLP | Associate | tax | Not stated |
| Laura Szarmach | Latham & Watkins LLP | Counsel | executive compensation and benefits | Not stated |
| Bryce Groce | Latham & Watkins LLP | Associate | executive compensation and benefits | Not stated |
| Steve Chinowsky | Latham & Watkins LLP | Partner | intellectual property | San Diego |
| Arun Mohan | Latham & Watkins LLP | Associate | intellectual property | Not stated |
| William Jackson | Latham & Watkins LLP | Associate | intellectual property | Not stated |
| Elizabeth Richards | Latham & Watkins LLP | Partner | healthcare regulatory | Washington, D.C. |
| Betty Pang | Latham & Watkins LLP | Partner | healthcare regulatory | Bay Area |
| Evan Rothkoff | Latham & Watkins LLP | Associate | healthcare regulatory | Not stated |
18 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 300m (US$300 million)
- What the figure measures
- Not stated
- Client
- Pelthos TherapeuticsBuy-side
- Counterparties
- Castle Creek Biosciences, Inc. (Sell-side)